Good day. And thank you for standing by. Welcome to the Telos Corporation third quarter, 2024 earnings call. (Operator Instructions) Please be advised that today's session is being recorded. I would ...

ZUG, Switzerland, Nov. 13, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that Oculis’ ...